Navigating the complex global patent landscape.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESPharmaceutical research and development is a complex, expensive, and risky process, often requiring years and substantial investment. Regulatory authorities valuate a drug's quality, safety, and efficacy through extensive nonclinical and clinical trial data before granting approval. Given the high costs and risks, protections like patents and Regulatory Data Protection (RDP) are crucial to incentivize these investments. Patents alone may not be sufficient to encourage pharmaceutical innovation in a competitive market. Therefore, RDP was introduced to provide additional incentives for pharmaceutical companies. RDP consists of two main components: Data Exclusivity (DE) and Market Protection (MP). The DE period prevents generic drug manufacturers from referencing the innovator's clinical trial data to obtain marketing approval for a certain number of years. MP refers to the period during which a generic version of a drug cannot be marketed, even if it has received regulatory approval. This ensures that the innovator maintains market exclusivity and profitability for a specified time. These periods vary across countries but generally start from the market authorization date of the original product.
Ark Patent Intelligence provides the most up-to-date data on RDP for 41 countries (including 27 countries in the European Union) in its Regulatory Protection module, offering valuable insights into the varying protection periods and regulations across different jurisdictions.
Download our comprehensive article to gain valuable insights into Regulatory Data Protection (RDP) in Switzerland and enhance your pharmaceutical investment strategies. Learn how RDP provisions can benefit your business by providing crucial protections and competitive advantages in the market.
Navigating the complex global patent landscape.
Maximize your generic portfolio.